Fintel reports that on September 4, 2025, Stifel initiated coverage of TransMedics Group (BMV:TMDX) with a Hold recommendation.

What is the Fund Sentiment?

There are 192 funds or institutions reporting positions in TransMedics Group. This is an increase of 3 owner(s) or 1.59% in the last quarter. Average portfolio weight of all funds dedicated to TMDX is 0.08%, an increase of 21.57%. Total shares owned by institutions increased in the last three months by 5.66% to 23,239K shares.

What are Other Shareholders Doing?

IJR - iShares Core S&P Small-Cap ETF holds 2,015K shares representing 7.42% ownership of the company. In its prior filing, the firm reported owning 2,074K shares , representing a decrease of 2.92%. The firm increased its portfolio allocation in TMDX by 91.89% over the last quarter.

FIL holds 1,056K shares representing 3.88% ownership of the company. In its prior filing, the firm reported owning 1,226K shares , representing a decrease of 16.15%. The firm decreased its portfolio allocation in TMDX by 14.22% over the last quarter.

VTSMX - Vanguard Total Stock Market Index Fund Investor Shares holds 1,029K shares representing 3.79% ownership of the company. In its prior filing, the firm reported owning 1,005K shares , representing an increase of 2.35%. The firm increased its portfolio allocation in TMDX by 81.99% over the last quarter.

Ubs Asset Management Americas holds 956K shares representing 3.52% ownership of the company. In its prior filing, the firm reported owning 3,113K shares , representing a decrease of 225.75%. The firm decreased its portfolio allocation in TMDX by 92.94% over the last quarter.

Macquarie Group holds 952K shares representing 3.50% ownership of the company. In its prior filing, the firm reported owning 1,116K shares , representing a decrease of 17.17%. The firm increased its portfolio allocation in TMDX by 87.44% over the last quarter.